BMS CLINIC / MEDICAL INSIGHTS
Medical & Health Information Center
Grounded in professional medical knowledge, explore practical insights into health management, medical testing, metabolic health, and various approaches to care, helping you gain a more comprehensive understanding of your personal health.
MEDICAL KNOWLEDGE / HEALTH EDUCATION / WELLNESS
EXPLORE OUR ARTICLES
Explore Medical & Health Articles
Browse by health topic or search by keyword to find articles of interest.
Can High-Dose Vitamin C Be Used Alongside Cancer Treatment? Evidence, Safety Risks, and Personalized Assessment
Many people with cancer feel exhausted during chemotherapy, lose appetite, sleep poorly, or worry that repeated infections mean their body cannot keep going. That is often when they ask what high-dose vitamin C has to do with cancer. The answer is not to treat vitamin C as a “natural anticancer drug.” It is to ask whether, at the right time, dose, and under medical supervision, it can form part of integrative oncology care—helping patients maintain strength, quality of life, and the ability to complete planned treatment.
Cancer Care Decision Dilemma: The Value Exploration of Onconomics Plus Integrated Analysis
In the process of cancer care, formulating a precise and personalized care plan has always been a major challenge. Traditional imaging and tumor marker tests are commonly used but often fail to comprehensively reflect the real-time dynamics and microscopic biological characteristics of tumors. With rapid advancements in liquid biopsy and genetic testing technologies, RGCC’s Onconomics Plus integrated analysis provides richer and more accurate data to support personalized care decisions, enabling healthcare teams to adjust care plans in a timely manner and ultimately improve patient prognosis and quality of life.
Continuous High-Dose Intravenous Vitamin C: An Early Safety Study in Patients with Advanced Cancer
High-dose intravenous vitamin C, or intravenous ascorbate, differs from routine oral vitamin supplementation because intravenous administration can produce substantially higher blood concentrations of ascorbate.
One important question in early clinical research was what would happen when higher-dose ascorbate was given continuously to patients with advanced cancer, particularly in terms of safety, tolerability, and plasma concentration.
Does Vitamin C Increase the Risk of Calcium Oxalate Kidney Stones? An Early Review of the Evidence
After vitamin C (ascorbic acid) is metabolised in the body, a proportion can be converted into oxalate. Because calcium oxalate is a major component of many common kidney stones, the relationship between vitamin C intake and kidney stone risk has long been debated.
This early review examined the available evidence from vitamin C absorption, renal handling, oxalate metabolism, urinary oxalate measurement, and population studies to assess whether higher vitamin C intake was associated with calcium oxalate kidney stones.
Environmental Toxin Testing Guide: Practical Steps From Exposure Risk to Personalized Health Management
An office that still smells after renovation, a damp and moldy bedroom, frequent meals of large ocean fish, or work that involves solvents, metals, and dust can all raise concern about environmental exposure. More often, fatigue, headache, poorer sleep, reduced concentration, or ongoing skin or digestive discomfort persist, yet routine tests do not give a clear answer.
High-Dose Intravenous Vitamin C Combined with Chemotherapy: An Early Clinical Study in Ovarian Cancer
One important direction in research on high-dose intravenous vitamin C (intravenous ascorbate) is to examine whether it can be used alongside standard chemotherapy while maintaining an acceptable safety profile and potentially reducing some chemotherapy-related adverse effects.
In ovarian cancer research, investigators conducted laboratory, animal, and human clinical studies. For patients, one of the most relevant components was a small randomised clinical trial evaluating the safety and early clinical findings of adding intravenous vitamin C to carboplatin and paclitaxel.
High-Dose Intravenous Vitamin C Combined with Standard Therapy: A Phase I Study in Metastatic Pancreatic Cancer
High-dose intravenous vitamin C (intravenous ascorbic acid) was initially studied on its own, but later early-phase clinical trials also began to evaluate its use alongside standard cancer medicines.
In patients with metastatic pancreatic cancer, one Phase I study assessed the safety and feasibility of intravenous ascorbic acid given together with gemcitabine and erlotinib.
High-Dose Intravenous Vitamin C: Safety Assessment and Supportive Care Planning in Cancer
When cancer treatment, prolonged fatigue, or recurrent infections place the body under strain, many patients ask whether high-dose vitamin C can help restore energy, support immune function, or make it easier to complete planned therapy. This is not a question that can be answered with a simple “suitable” or “not suitable.” Intravenous vitamin C should only become a meaningful part of overall care after diagnosis, kidney function, medications, treatment timing, and personal goals have been taken into account.
High-Dose Vitamin C and Advanced Cancer: Revisiting the Early Clinical Study by Cameron and Campbell
Research into high-dose vitamin C in cancer medicine is not a recent development. As early as 1974,
Cameron and Campbell published a clinical study involving patients with advanced cancer, which later
became one of the important early papers in this field.
Health Information Should Be Considered in the Context of Individual Needs
The medical and health information provided on this website is intended for general health education and informational purposes only. It is not a substitute for professional medical diagnosis, clinical assessment, or personalised medical advice.
Every individual has different health conditions, medical histories, physiological responses, and healthcare needs. The medical research, health screenings, medications, and health management approaches discussed in our articles may not be suitable for everyone. Their inclusion does not imply that these approaches have been proven effective for all individuals or medical conditions.
If you have questions or concerns about your health, test results, or treatment options, we recommend consulting a qualified medical practitioner. A doctor can provide a professional assessment based on your individual circumstances and discuss appropriate approaches to managing your health.
Book a Consultation